Pharma-Bio Serv, Inc.
PBSV
$0.55
$0.07515.79%
| 10/31/2024 | 07/31/2024 | 04/30/2024 | 01/31/2024 | 10/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 2.33M | 2.42M | 2.38M | 2.38M | 3.60M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 2.33M | 2.42M | 2.38M | 2.38M | 3.60M |
| Cost of Revenue | 1.61M | 1.78M | 1.76M | 1.84M | 2.67M |
| Gross Profit | 726.60K | 635.40K | 618.50K | 535.60K | 929.80K |
| SG&A Expenses | 880.70K | 1.02M | 931.90K | 973.90K | 981.60K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.49M | 2.80M | 2.69M | 2.82M | 3.65M |
| Operating Income | -154.10K | -381.80K | -313.40K | -438.30K | -51.80K |
| Income Before Tax | -14.80K | -290.20K | -192.60K | -257.80K | -47.80K |
| Income Tax Expenses | -31.00K | 19.00K | 21.20K | 12.90K | -700.00 |
| Earnings from Continuing Operations | 16.10K | -309.20K | -213.80K | -270.70K | -47.10K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 16.10K | -309.20K | -213.80K | -270.70K | -47.10K |
| EBIT | -154.10K | -381.80K | -313.40K | -438.30K | -51.80K |
| EBITDA | -148.20K | -377.20K | -307.90K | -431.00K | -44.40K |
| EPS Basic | 0.00 | -0.01 | -0.01 | -0.01 | 0.00 |
| Normalized Basic EPS | 0.00 | -0.01 | -0.01 | -0.01 | 0.00 |
| EPS Diluted | 0.00 | -0.01 | -0.01 | -0.01 | 0.00 |
| Normalized Diluted EPS | 0.00 | -0.01 | -0.01 | -0.01 | 0.00 |
| Average Basic Shares Outstanding | 22.97M | 22.96M | 22.96M | 22.96M | 23.00M |
| Average Diluted Shares Outstanding | 22.97M | 22.96M | 22.97M | 22.99M | 23.00M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | 0.00% | -- | -805.47% | -- | 0.00% |
